Protein kinase C inhibitor anchored BRD4 PROTAC PEGylated nanoliposomes for the treatment of vemurafenib-resistant melanoma
Yige Fu, Drishti Rathod, Ketan Patel
Topics & Concepts
VemurafenibVasculogenic mimicryCancer researchMatrigelBiologyAngiogenesisHuman umbilical vein endothelial cellMelanomaProtein kinase APharmacologyKinaseUmbilical veinBiochemistryIn vitroMetastasisCancerGeneticsMetastatic melanomaProtein Degradation and InhibitorsMultiple Myeloma Research and TreatmentsUbiquitin and proteasome pathways